Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 15 items

Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion

Dresler, Carolyn M. , Olak, Jemi , Herndon, James E. ... - - Chest - 2005

Manuscript - Primary - Primary - Respiratory - CALGB-9334

The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from Cancer and Leukemia Group B 9480.

George, Daniel J , Halabi, Susan , Shepard, Timothy F , Sanford, Ben ... - - Clin Cancer Res - 2005

Manuscript - Primary - Primary - GU - INT-0159

Prospective Phase II Trial of Pre-Resection Thoracoscopic (VATS) Restaging Following Neoadjuvant Therapy For IIIA(N2) Non-small Cell Lung Cancer (NSCLC): Results of CALGB 39803

Jaklitsch, M. T. , Gu, L. , Harpole, D. H. , D'Amico, T. A. ... - - J Clin Oncol - 2005

Abstract - Primary - Primary - Respiratory - CALGB-39803

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: The Cancer and Leukemia Group B (study 9730).

Lilenbaum, Rogerio C , Herndon, James E , List, Marcy A ... - - J Clin Oncol - 2005

Manuscript - Primary - Primary - Respiratory - CALGB-9730

Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma

Mamon, H. J. , Niedzwiecki, D. , Hollis, D. R. , Tan, B. , Smith, J. ... - - Int J Radiat Oncol Biol Phys - 2005

Abstract - Primary - Preliminary - GI - CALGB-80003

A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).

McClay, Edward F , Bogart, Jeff , Herndon, James E , Watson, Dee ... - - Am J Clin Oncol - 2005

Manuscript - Primary - Primary - Respiratory - CALGB-9235

Combined-modality therapy of poor prognosis anal canal carcinoma: a phase II study of the Cancer and Leukemia Group B (CALGB)

Meropol, N. J. , Niedzwiecki, D. , Shank, B. , Colacchio, T. ... - ASCO GI - Gastrointestinal Cancers Symposium - 2005

Abstract - Primary - Primary - GI - CALGB-9281

Phase II trial of paclitaxel-topotecan-etoposide (PTE) followed by consolidation chemoradiotherapy for limited stage small cell lung cancer (LS-SCLC): CALGB 30002

Miller, A. A. , Bogart, J. A. , Watson, D. M. , Wang, X. F. ... - - J Clin Oncol - 2005

Abstract - Primary - Primary - Respiratory - CALGB-30002

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

Moore, Joseph O. , George, Stephen L. , Dodge, Richard K. ... - - Blood - 2005

Manuscript - Primary - Primary - Leukemia - CALGB-9222

Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

Niell, Harvey B , Herndon, James E , Miller, Antonius A ... - - J Clin Oncol - 2005

Manuscript - Primary - Primary - Respiratory - Alliance-9732

Updated analysis of a Phase III study of surgical resection and chemotherapy (paclitaxel/carboplatin) (CT) with or without adjuvant radiation therapy (RT) for resected stage III non-small cell lung cancer (NSCLC) CALGB 9734

Perry, M. C. , Kohman, L. , Bonner, J. , Gu, L. , Wang, X. , Vokes, E. ... - - J Clin Oncol - 2005

Abstract - Primary - Long-Term-Followup - Respiratory - CALGB-9734

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.

Peters, William P , Rosner, Gary L , Vredenburgh, James J ... - - J Clin Oncol - 2005

Manuscript - Primary - Primary - Breast - CALGB-9082

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

Romond, Edward H , Perez, Edith A , Bryant, John , Suman, Vera J ... - - N Engl J Med - 2005

Manuscript - Secondary-not-in-original - Primary - Breast - NCCTG-N9831

CALGB 30103: A randomized phase II study of carboplatin and etoposide (CE) with or without G3139 in patients with extensive stage small cell lung cancer (ES-SCLC).

Rudin, C. M. , Salgia, R. , Wang, X. F. , Green, M. R. ... - - J Clin Oncol - 2005

Abstract - Primary - Primary - Respiratory - CALGB-30103

A Phase II Study of Carboplatin, Etoposide and Exisulind in Patients with Extensive Stage Small Cell Lung Cancer: CALGB 30104

Wang, X. F. , Govindan, R. , Herndon, J. E., 2nd , Barrier, R. C. ... - - J Clin Oncol - 2005

Abstract - Primary - Primary - Respiratory - CALGB-30104